To evaluate the efficacy of sacubitril/valsartan versus enalapril on changes in NT-proBNP and the safety and tolerability of in-patient initiation of sacubitril/valsartan compared to enalapril in patients admitted for heart failure.
Principal Investigator: Steven Kindsvater, MD
Locations: Baylor Scott & White The Heart Hospital – Plano and Baylor Scott & White Medical Center McKinney
IRB Number: 017-093
Trial Status: Enrolling
Exclusions: Adults only
Change in Care: Participating will change your care
Alexandria Biberstein, RN469.814.4732Alexandria.Biberstein@BSWHealth.org
A multicenter, randomized, double-blind, double-dummy, parallel group, active-controlled 8-week study to evaluate the effect of sacubitril/valsartan (LCZ696) versus enalapril on changes in NT-proBNP and safety and tolerability of in-hospital initiation of sacubitril/valsartan compared to enalapril in HFrEF patients who have been stabilized following hospitalization for acute decompensated heart failure (ADHF).
Get Detailed Information On Clinicaltrials.gov »
Physicians are members of the medical staff at one of Baylor Scott & White Health's subsidiary, community or affiliated medical centers and are neither employees nor agents of those medical centers, Baylor Scott & White The Heart Hospital – Plano or Baylor Scott & White Health.